Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
The Pharmacogenomics Journal
|
November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis
E K Morgen, H-J Lenz, D J Jonker, et al.
Plos One
|
January 6, 2011
Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis
Bünyamin Akgül, Kai-Wei Lin, Hui-Mei Ou Yang, et al.
Current Oncology (Toronto, Ont.)
|
December 17, 2008
The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group
K S Courneya, C M Booth, S Gill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)
K M Wasan, P E Goss, P H Pritchard, et al.
Lancet (London, England)
|
December 17, 2008
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis
, P Blake, Ann Marie Swart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2013
Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC)
Y Yan, X Li, A Blanchard, et al.
Journal of Pediatric Urology
|
May 11, 2016
Imaging characteristics associated with failure of nonoperative management in high-grade pediatric blunt renal trauma
J K Au, X Tan, M Sidani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3
M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
T R Asmis, E Powell, C S Karapetis, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
The Pharmacogenomics Journal
|
November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis
E K Morgen, H-J Lenz, D J Jonker, et al.
Plos One
|
January 6, 2011
Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis
Bünyamin Akgül, Kai-Wei Lin, Hui-Mei Ou Yang, et al.
Current Oncology (Toronto, Ont.)
|
December 17, 2008
The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group
K S Courneya, C M Booth, S Gill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)
K M Wasan, P E Goss, P H Pritchard, et al.
Lancet (London, England)
|
December 17, 2008
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis
, P Blake, Ann Marie Swart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2013
Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC)
Y Yan, X Li, A Blanchard, et al.
Journal of Pediatric Urology
|
May 11, 2016
Imaging characteristics associated with failure of nonoperative management in high-grade pediatric blunt renal trauma
J K Au, X Tan, M Sidani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3
M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
T R Asmis, E Powell, C S Karapetis, et al.
Page
of 13